Literature DB >> 1945321

Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease.

K D Carter1, B R Frueh, T P Hessburg, D C Musch.   

Abstract

In a retrospective evaluation of the long-term effect of transantral-ethmoidal decompression for compressive optic neuropathy, the authors evaluated visual acuity, visual fields, color vision, and motility in 30 patients (52 orbits) for a median follow-up period of 2.5 years (range, 0.6 to 6.5 years). Patients with preoperative visual acuity of 20/40 or better uniformly remained in this category and demonstrated an earlier stabilization of vision than those with poorer preoperative visual acuity. Of the ten patients whose preoperative visual acuity was 20/50 to 20/100, 80% attained acuity of 20/40 or better. In patients whose visual acuity was 20/200 or less (n = 7), 57% attained an acuity of 20/40 or better. The most common visual field defect was generalized constriction, which was noted in 43 of the 52 eyes (83%). After decompression, the preoperative visual field defect had improved or completely resolved in all but one case. Dyschromatopsia, noted in 20 eyes preoperatively, cleared in 17 (85%) postoperatively. Although the study showed that surgical decompression is beneficial, some patients may require additional modalities of treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1945321     DOI: 10.1016/s0161-6420(91)32115-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.

Authors:  H C Kim; S W Yoon; H Lew
Journal:  Br J Radiol       Date:  2015-07-07       Impact factor: 3.039

2.  Effects of bilateral orbital decompression by an endoscopic endonasal approach in dysthyroid orbitopathy.

Authors:  A Neugebauer; K Nishino; P Neugebauer; W Konen; O Michel
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

3.  A novel technique for the measurement of eyelid contour to compare outcomes following Muller's muscle-conjunctival resection and external levator resection surgery.

Authors:  Jennifer Danesh; Shoaib Ugradar; Robert Goldberg; Daniel B Rootman
Journal:  Eye (Lond)       Date:  2018-05-24       Impact factor: 3.775

4.  Changes in optical coherence tomography measurements after orbital wall decompression in dysthyroid optic neuropathy.

Authors:  Kyung-Ah Park; Yoon-Duck Kim; Kyung In Woo
Journal:  Eye (Lond)       Date:  2018-03-01       Impact factor: 3.775

5.  Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.

Authors:  Chan Jeon; Jae Ho Shin; Kyung In Woo; Yoon-Duck Kim
Journal:  Korean J Ophthalmol       Date:  2012-03-22

6.  Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis.

Authors:  Ozgun Melike Gedar Totuk; Meltem Guzin Altinel; Ayse Yagmur Kanra; Umit Aykan
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

7.  Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results.

Authors:  Mehmet Ozgur Cubuk; Onur Konuk; Mehmet Unal
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

8.  Transcaruncular medial wall orbital decompression: an effective approach for patients with unilateral graves ophthalmopathy.

Authors:  Robert H Hill; Craig N Czyz; Thomas A Bersani
Journal:  ScientificWorldJournal       Date:  2012-04-30

9.  Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy.

Authors:  Mohammad Taher Rajabi; Mina Ojani; Hamid Riazi Esfahani; Seyed Zia Tabatabaei; Mohammad Bagher Rajabi; Seyede Simindokht Hosseini
Journal:  J Curr Ophthalmol       Date:  2018-12-21

Review 10.  Strategies in Surgical Decompression for Thyroid Eye Disease.

Authors:  Anny M S Cheng; Yi-Hsuan Wei; Shu-Lang Liao
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.